Crescera Capital Acquisition to Liquidate

Crescera Capital Acquisition in an 8-K said its board has decided to redeem shares and liquidate the blank-check company effective Dec. 6 because it will not complete a deal by deadline. The filing did not state a redemption price for shares.

The Nasdaq delisted Crescera Capital shares in July and the SPAC has traded OTC since then.

The SPAC raised $175 million in a November 2021 IPO to raise capital for the acquisition of a Latin American company. Read more.

Total
0
Shares
Related Posts
Read More

Lazard Healthcare I Withdraws $250M IPO

The SPAC in its S-1 filing from March 2021 noted plans to target the biotechnology, medical technology, life science tools and diagnostics, healthcare information technology and technology-enabled healthcare services subsectors.